Diabetes [39], as well as HbA1c [32] and serum glucose levels [33], have been linked to a lower incidence of prostate cancer, partly because of the lower level of insulin-like growth factor-1 levels in diabetic patients, and partly because of the potential detection bias due to the lower PSA level in diabetic men [32, 39]. This evidence concerns the gene KLK3 and prostate cancer.